Cytotoxicity and apoptosis induction of weisiensin B isolated from Rabdosia weisiensis C.Y. Wu in human hepatoma cells

Journal of Asian Natural Products Research

Volumn 10, Issue 11, 2008, Pages 1055-1062

  Ding, Lan ^a   Zhang, Shi Dong ^a   Yang, Dong Juan ^b   Liu, Bo ^a   Zhou, Qi Yin ^a   Yang, Hong ^a  

^a NORTHWEST NORMAL UNIVERSITY   (China)

^b HANSHAN NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cycle arrest; ent kaurane diterpenoids; Weisiensin B

Indexed keywords

CYTOTOXIC AGENT; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; WEISIENSIN B;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; FLOW CYTOMETRY; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; RABDOSIA WEISIENSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MOLECULAR STRUCTURE; RABDOSIA;

RABDOSIA;

EID: 56749133030     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020802318941     Document Type: Article

References (26)

1. D. Yim, R.P. Singh, C. Agarwal, S. Lee, H. Chi, and R. Agarwal, Cancer Res. 65, 1035 (2005).
2. H.D. Sun, Y.L. Xu, and B. Jiang, Diterpenoids from Isodon Species (Science Press, Beijing, 2001), pp. 4-13.
3. J.J. Liu, R.W. Huang, X.L. Pan, and J. Peng, Chin. Tradit. Patent Med. 26, 1027 (2004).
4. J.F. Zhang, J.J. Liu, P.Q. Liu, D.G. Lin, X.D. Li, and G.H. Chen, Hepatol. Res. 35, 104 (2006).
5. J.W. Liu, F. Yang, Y. Zhang, and J.Y. Li, Int. Immunopharmacol. 7, 945 (2007).
6. Q. Cui, S. Tashiro, S. Onidera, M. Minami, and T. Ikejima, Biol. Pharm. Bull. 30, 859 (2007).
7. L. Ding, Z.J. Zhang, G.A. Liu, D.J. Yang, G.C. Guo, and H. Wang, Helv. Chim. Acta. 88, 2502 (2005).
8. A. Itharat, P.J. Houghton, E.E. Amooquaye, P.J. Burke, J.H. Sampson, and A. Raman, J. Ethnopharmacol. 90, 33 (2004).
9. K. Shailaja and T. Ben, Mol. Cancer Ther. 2, 573 (2003).
10. R. Johnstone, A. Ruefli, and S. Lowe, Cell 108, 153 (2002).
11. J. Bartek, C. Lukas, and J. Lukas, Nat. Rev. Mol. Cell Boil. 5, 792 (2004).
12. T.V. Rakitina, I.A. Vasilevskaya, and P.J. O'Dwyer, Biochem. Pharmacol. 73, 1715 (2007).
13. W. Yin, X.K. Deng, F.Z. Yin, X.C. Zhang, and B.C. Cai, Food Chem. Toxicol. 45, 1700 (2007).
14. D. Chu, J.X. Qiu, M. Grafe, R. Fabian, T.A. Kent, D. Rassin, O. Nesic, K. Werrbach-Perez, and R. Perez-Polo, Neurochem. Res. 27, 97 (2002).
15. X.L. Li, J. Wang, and L.M. James, Genes Dev. 19, 2705 (2005).
16. Q. Chen, W.L. Peng, and A.L. Xu, Biochem. Pharmacol. 63, 1389 (2002).
17. R.P. Singh, S. Dhanalakshmi, and R. Agarwal, Cell Cycle 1, 156 (2002).
18. J. Kluza, A. Lansiaux, N. Wattez, C. Mahieu, N. Osheroff, and C. Bailly, Cancer Res. 60, 4077 (2000).
19. S. Chen, J. Gao, H.D. Halicka, X. Huang, F. Traganos, and Z. Darzynkiewicz, Int. J. Oncol. 26, 579 (2005).
20. K.K. Ren, H.Z. Wang, L.P. Xie, D. Chen, X. Liu, J. Sun, Y.C. Nie, and R.Q. Zhan, J. Ethnopharmacol. 103, 176 (2006).
21. T. Hsieh, E.K. Wijeratne, J.Y. Liang, A.L. Gunatilaka, and J.M. Wu, Biochem. Biophys. Res. Commun. 337, 224 (2005).
22. A. Skladanowski, Apoptosis 7, 347 (2002).
23. M.G. Liu, P.Y. Yue, Z. Wang, and R.N. Wong, Cancer Lett. 224, 229 (2005).
24. A.E. Santiago-Walker, A.J. Fikaris, G.D. Kao, E.J. Brown, M.G. Kazanietz, and J.L. Meinkoth, J. Biol. Chem. 280, 32107 (2005).
25. S.K. Bae, J.H. Back, Y.M. Lee, and K.W. Kim, Cancer Lett. 126, 97 (1998).
26. D.T.P. Trafalis, Cancer Lett. 243, 202 (2006).